Summary The mechanism of action of 2-chlorpromazine (2-chloro-10-(3-dimethylaminopropyl)-phenothiazine) as a reversal agent for P-glycoprotein-mediated multidrug resistance was investigated using inside out-orientated membrane vesicles prepared from vinblastineresistant human CCRF-CEM leukaemia cells (VBL,,, vinblastine (V) and the two extemal sites are occupied by 2-chlorpromazine (C). When the two binding sites on both the inside and outside of P-glycoprotein are saturated with ligands vinblastine is effluxed at a very rapid rate. and vice versa when vesicles are preloaded with 2-chlorpromazine and vinblastine is added outside. These unexpected observations and the concerted model developed provide an altemative mechanism of action for reversal agents that sensitize multidrug-resistant cancer cells to anti-cancer drugs.
A common clinical problem in the treatment of cancer is the dev-elopment of resistance to multiple chemotherapeutic agents. Tumour cells grown in the presence of a single anti-cancer drug mar become resistant to a w-ide range of structurallx dissimilar drugs (FOjo et al. 1985: Arias. 1990-. In cell culture. this phenomenon. known as multidrug resistance (NIDR) . has been show-n to be due to oxerexpression of the MXDR-1 gene. which encodes P-glycoprotein . P-glycoprotein is a membraneassociated M1-'-dependent ATPase and uses the energy of ATP hx drolI-sis to pump drugs out of cells. thereby reducing their intracellular concentrations and hence their c-totoxicities (Hamada and Tsuruo. 1988) .
The mechanism by w-hich P-glycoprotein. a 170-to 180-kDa protein. recognizes and extrudes a large number of diverse compounds is not yet clear. Howxever. recent wvork using different combinations of drugs to studv drug, binding, to P-glxcoprotein. or drua efflux mediated by the protein. suggests that there may be more than one site on P-gl^-coprotein to which substrates bind and are subsequently transported across the membrane (Tamai and Safa. 1991 : Ferr-et al. 1992 : Spoelstra et al. 1992 : Malkhandi et al. 1994 ).
Received 9 September 1997 Revised 3 February 1998 Accepted 4 February 1998 Correspondence to: BD Roufogalis Narious compounds reverse MIDR and make cells sensitixve to anti-cancer drugs. These 'chemosensitizers' include calcium channel blockers (e.g. -erapamil: Tsuruo et al. 1982) . calmodulin antagonists (e.g. phenothiazines: Ford et al. 1989) . the antiarrhvthmic agent quinidine (Hofsli and Nissen-NMever. 1990 ) and the immune suppressor cyclosporin A (Nooter et al. 1989) . These compounds are not only xvery different from each other in structure but also have quite different effects on cellular physiology and are often cytotoxic on their oi-n. Verapamil is a competitive inhibitor with respect to some substrates of P-gl coprotein (Sehested et al. 1990 ) but is non-competitixe w-ith others (Pereira et al. 1994) . Howexer. the mechanism of action of the phenothiazines. such as 2-chlorpromazine (2-CPZ) and trifluoperazine.
is not clear.
Elucidation of the mechanism of rex ersal of MDR by different chemosensitizers is important for the dexvelopment of newi chemotherapeutic strategies to oxercome this resistance. We hax e prex iously reported drug transport studies in inside-out membrane xesicles prepared from human CCRF CEM-VBL multidrug-resistant cells (Syed et al. 1993 (Syed et al. . 1996 . Membrane x-esicles offer a unique s5ystem for studyving the mechanisms bv which different chemosensitizers exert their effects on P-glycoprotein-mediated drug transport. Using this system. we report here studies on the mechanism of action of 2-CPZ. a potential chemosensitizer. and a closely related structural analogyue (Ford et al. 1989 Cell culture and membrane vesicle preparation Human CCRF-CEM leukaemia cells and the vinblastine-resistant mutant cell line. CEMIVBL0OOO. were grown in 2-1 cultures of RPMI-1640 medium containing 10% (v/v) fetal calf serum and 50 jg ml-' gentamicin. The method of membrane preparation was essentially as described previously (May et al. 1988 : Syed et al. 1993 . Cells were harvested at a density of 8 x 10-i cells ml-'. washed three times with phosphate-buffered saline and suspended in 5 volumes of 'cavitation buffer' (10 mm Tris-HCI. pH 7.4. 250 mM sucrose. 0.2 =m calcium chloride. 10 m,rm leupeptin and 1 mm phenylmethylsulphonyl fluoride). They were then disrupted by cavitation under nitrogen pressure at 500 psi for 15 min at 4°C. EDTA was added to the cell homogenate to a final concentration of 1 mM and the homogenate centrifuged at 1000 g for 10 min to remove cellular debris. The supematant was saved and the pellet was disrupted again in 2 volumes of cavitation buffer at 500 psi for 10 min. After centrifugation at 1000 g for 10 min, the two supernatants were pooled and layered over 35% (w/v) sucrose in 10 mm Tris-HCl. pH 7.4 and centrifuged at 16 000 g for 50 min Vesicles at the supematant-sucrose interface were collected, diluted in 10 mm Tris-HCl, pH 7.4 and 250 mm sucrose (buffer A) and centrifuged at 105 000 g for 1 h. The pellet was then suspended in buffer A and frozen immediately at -70°C.
Drug accumulation by membrane vesicles
Accumulation of VBL and 2-CPZ by membrane vesicles was measured essentially as described previously (Horio et al, 1988 : Syed et al. 1993 . Briefly. 20 jl of vesicles (5 mg protein ml-') was added to 30 jl of ATP-containing buffer (10 mM Tris-HCl. pH 7.5. 1 mM ATP. 10 mm magnesium chloride. 10 mm creatine phosphate. 250 mm sucrose and 100 jg ml-' creatine phosphokinase) at 25°C. The reaction was started by the addition of 50 jl of reaction medium containing 120 n-m [3H]VBL or 2-[3H]CPZ in buffer A. At appropriate times the reaction was terminated by addition of 4 ml of ice-cold buffer A and the mixture immediately applied to cellulose acetate filters (0.45 m. Microfiltration System. Japan) under vacuum. The filters were washed once with buffer A. dried and counted in 6 ml of scintillation cocktail (Emulsifier-Safe. Packard, USA). Non-ATP-dependent association of the radiolabelled drug with the vesicles and filter was determined with incubation medium lacking ATP and the ATP regenerating system or containing AMP instead. These counts were subtracted from the total counts (in the presence of ATP) to give ATP-dependent specific uptake of the drug.
Plots presented are representative of three separate experiments carried out in duplicate.
Calcium accumulation experiments
Calcium uptake by membrane vesicles was measured essentially as described by Shibata and Ghishan (1990 (1965) where the acceptor (P-glycoprotein) has two independent ligand (vinblastine)-binding sites (see Scheme 1).
RESULTS

Effect of 2-chlorpromazine on vinblastine accumulation
Membranes prepared from multidrug-resistant human leukaemia cells (CCRF-CEM/VBL1O) by high-pressure cavitation and differential centrifugation form a mixture of inside-out and right side-out membrane vesicles (Syed et al. 1993) . Inside-out orientated vesicles actively accumulate VBL in a time-dependent manner. Greater than 90% of the total uptake was ATP dependent. To understand the MDR-modulating mechanism of 2-CPZ. we studied its effect on VBL accumulation by membrane vesicles. (Azzaria et al. 1989 : Rosenbera et al. 1997 . There is evidence that hvdrol1sis of ATP at both sites is required for substrate transport (see Stein. 1997) .
Mlost of the compounds transported Xia P-glycoprotein are lipophilic and cationic at physiological pH (Beck and Qian. 1992 ). This broad specificitx has suggested that lipophilic compounds A ith low-toxicitV could be used to saturate and thereby functionally inactix ate P-glvcoprotein. enablincg the British Joumal of Cancer (1998) 78(3 considerably more rapid than the initial rate of accumulation. being 80' complete within 5 min after 2-CPZ addition. A number of possible mechanisms for this unexpected effect w-ere considered. Phenothiazines are membrane-actiVe agents that can disrupt membrane structure and lead to cell ly sis and increased membrane permeability (Saito et al. 1989 ).
How-ever. the rapid [VH]VBL efflux following 2-CPZ addition did not appear to be due to a general increase in membrane permeability. as in a parallel experiment addition of the same concentration of 2-CPZ (10 P%\o to vesicles at steady state of 'Ca> accumulation catal-sed by the Ca:--pump ATPase did not cause 4'Ca' to efflux from the vesicles (Figure 3 ). This result suggests that under the conditions used the effect of 2-CPZ is selecti-e for the P-l-coprotein-mediated transport process. Similar rapid effluxes A-ere seen when unlabelled VBL A-as (Syed et al. 1996) . The pathway for VBL efflux from the inside-out v esicles. equix alent to influx in riaht side-oriented cancer cells. is not know-n. The rapid efflux of ['H]VBL wxas specific to P-glycoprotein ligands (unlabelled VBL or 2-CPZ). as blockinc of vinblastine transport by complete inhibition of the ATPase activitv of P-glycoprotein with sodium -anadate induced [IH] VBL efflux at a rate corresponding to the initial rate of VBL accumulation (Figure 2) . Ahen 2-CPZ was added w ith x-anadate. a rate of efflux intermediate betv een those observed after addition of 2-CPZ and vanadate singlx was observed (Figure 2) .
Data for the initial accumulation of VBL or 2-CPZ by P-glxcoprotein by inside-out *-esicles and the effects of inhibitors of druc accumulation are consistent w ith the concerted model of Monod et al (1965) . in which P-glx coprotein has tmo binding sites for drucs on the outside of vesicles (consistent svith a Hill coefficient of 1.23) and two on the inside. These pairs of sites have a similar affinity for the drug. either both hiah or low. hence the term .concerted model'. We propose that P-glxcoprotein exists in two conformational states. P, and PB* 2-CPZ is bound and transported by PA. whereas VBL is not. and PB binds and transports VBL but not CPZ. The various species of P-glx coprotein present initiallx are show-n in Scheme 1. cles. This concerted model can be extended to the subsequent steady state w-here VBL has accumulated in vesicles and '-CPZ is then added. inducing a ver-rapid efflux of VBL from the preloaded vesicles (Figure 1 ). We propose that in preloaded vesicles the tuo internal binding, sites of P-l coprotein (facingy the vesicle lumen) are occupied by VBL at saturating internal concentrations. indicated by the ligands )VV) written to the left of the acceptor. P,:
British Joumal of Cancer (1998) 78 (3) where the saturated P-glycoprotein complex. VV.P .CC. with VBL bound on the inside and 2-CPZ bound on the outside. enables the very rapid efflux of VBL observed from the steady state when 2-CPZ is added (Figure 1 ). The converse is also true: there is very rapid efflux of 2-CPZ accumulated in vesicles to a steady state when VBL is then added (see Syed et al. 1996) , because of formation of the saturated complex. CC.PB.W. which rapidly effluxes 2-CPZ. There are several reasons why P-glycoprotein may exist in two conformational states with specificity for VBL or CPZ. It has been proposed that P-glycoprotein is able to pump out hydrophilic drugs from the intemal aqueous cytosol of cells (see Higgins and Gottesman. 1992 ) and also. lipid-soluble drugs may be pumped out from the lipid bilayer (Rosenberg et al, 1997) . The reason for putative differential transport pathways is not known. P-glycoprotein may have one conformational state. P A which binds and pumps classes of drugs such as 2-CPZ from one site in the lipid bilayer into vesicles and a second conformational state. PB. which binds and pumps drugs such as VBL from a different lipid phase into vesicles. All the saturated complexes of P-glycoprotein (VV.P,,.CC. CC.PBWV and VV.PB.VV) would rapidly efflux the internal ligand of the inside-out vesicles (on the left) to the exterior. We have found that verapamil has similar inhibitory effects on VBL uptake to 2-CPZ: it also induces the rapid efflux of VBL from preloaded vesicles (cf. Figure 1) and sigmoidality in the saturation curve for VBL uptake as a function of VBL concentration (cf. Figure 4B : data not shown).
The data of Table 1 provide further evidence that P-glycoprotein may exist in two conformational states. Colchicine and phenoxybenzamine are effective inhibitors of VBL uptake by vesicles. but at the same concentrations have little effect on the uptake of 2-CPZ. There is evidence for distinct sites on P-glycoprotein for substrates and chemosensitizers. Whereas vincristine, VBL. verapamil and reserpine effectively inhibit binding of a photoaffinity analogue of VBL and azidopine to P-glycoprotein. inhibition by the phenothiazines, 2-CPZ and trifluoperazine. and by chloroquine. is poor (Safa et al. 1986; Akiyama et al, 1988) .
The concerted, two-state model of Schemes 1 and 2 is also consistent with the inhibition of VBL accumulation by vanadate (Figure 2) . Addition of vanadate to vesicles that had accumulated VBL to the steady-state level resulted in efflux of VBL at a similar rate to the initial accumulation rate as a result of inhibition of the ATPase activity of P-glycoprotein (Figure 2) . We conclude that the saturated complexes of P-glycoprotein can only rapidly efflux the intemal ligand with concurrent ATPase activity. The finding that P-glycoprotein acts efficiently as a drug -efflux pump with low but not high concentrations of anti-cancer agents outside target cells (Miyamoto et al. 1996 ) might be accounted for by rapid influx of the anti-cancer agents through the pump. consistent with data presented here, or by inhibition of the efflux pathway in intact cells when extemal sites are saturated.
The model can also account for the transitory inhibition of VBL accumulation induced by addition of 4-CPZ at steady state ( Figure 5 ). When 4-CPZ is added at the steady state for VBL transporL the complex VV.P,,CC would be formed, with consequent rapid efflux of VBL ( Figure 5 ). However, with the loss of VBL from inside the vesicle upon its rapid efflux. the complex P A.CC would predominate and if the dissociation constant Kc were higher for 4-CPZ than for 2-CPZ, VBL could bind to form PBNV. with dissociation of the 4-CPZ. At this stage. the transport of VBL would resume. as shown in Figure 5 . This effect should be reversed on a second addition of 4-CPZ, as was indeed found to be the case. Ford et al (1989) have shown the importance of substitution at the 2-position of ring C of the phenothiazines for anti-MDR activity and demonstrated that 2-CPZ has a higher MDR ratio than 4-CPZ. The significance of this oscillatory behaviour of the P-glycoprotein pump remains to be determined.
The minimal concerted two-state model summarized in Schemes 1 and 2 is consistent with the data presented in this paper. Equation 3 derived from the concerted model proposed here for P-glycoprotein (Schemes 1 and 2) was able to satisfactorily simulate the data shown for VBL uptake in the absence or presence of 2-CPZ ( Figures 4A and B) . but in the absence of 2-CPZ the data was well approximated by a simple hyperbolic function (equation 1. Fig. 4A ). We propose to further test and refine this model using a continuous, real-time assay rather than the stopped-time radioassay used here. This model provides an alternative explanation for the mechanism of action of reversal agents that sensitize multidrug-resistant cancer cells to anti-cancer drugs. A non-toxic reversal agent could be administered first to the patient to bind to internal sites in cells of the right side-out P-glycoprotein. A cytotoxic drug such as vinblastine subsequently administered could then rapidly enter multidrug-resistant cells with high levels of Pglycoprotein via saturated complexes formed because of internal binding of the reversal agent. Thus. all cells expressing high levels of P-glycoprotein would be selectively exposed to the subsequently administered anti-cancer drug. ABBREVIATIONS MDR. multidrug resistance: VBL, vinblastine: 2-CPZ. 2-chlorpromazine (2-chloro-1-(3-dimethylaminopropyl)-phenothiazine)-4-CPZ, 4-chlorpromazine (4-chloro-1043-dimethylaminopropyl)-phenothiazine).
